• 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • All
Custom range
Custom range

EYPT AI-Powered Stock Analysis

AI Score Explanation

Danelfin Loading

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Alpha Factors

These AI Factors group the most impactful alpha signals used by Danelfin's AI to calculate the stock’s probability advantage. Positive factors (green) increase the probability of beating the market, while negative factors (red) reduce it.

  • Momentum+3.79%
    Direction and strength of recent price movements
  • Valuation+3.28%
    How the stock is priced relative to its fundamentals
  • Sentiment+2.34%
    How analysts and the market view the stock
  • Earnings Quality+1.54%
    Stability and reliability of reported earnings
  • Size & Liquidity+0.31%
    Company size and trading liquidity
  • Profitability-0.60%
    Profitability and operating efficiency metrics
  • Volatility-0.21%
    How much the stock price tends to fluctuate

EYPT probability advantage of beating the market (3M):

+10.44%

Alpha Signals: What Drives the AI Score

Alpha Signals show the individual signals used by Danelfin's AI to calculate a stock's probability of beating the market over the next 3 months. Each signal highlights its positive or negative impact on the probability advantage and helps explain what is driving the AI Score.

AI Score
Buy

EyePoint Pharmaceuticals (EYPT) has an AI Score of 8/10 (Buy) because, according to an overall analysis, it has a probability advantage of +10.44% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of EYPT (61.25%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

  • Average probability of any US-listed stock of beating the market (3M)50.82%
  • EYPT probability advantage of beating the market (3M)+10.44%
  • EYPT probability of beating the market (3M)61.25%

EYPT probability advantage of beating the market (3M): +10.44%

The AI-powered overall analysis of EyePoint Pharmaceuticals (EYPT) is based on the 27 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of EYPT:

Type
Alpha Signal
Current Value
Value Decile Position
Probability Advantage Impact (3M)
Fundamental
Fundamentals Impact (Long Tail)
-
N/A
+3.20%
Sentiment
Industry (GICS)
Pharmaceuticals
N/A
+1.94%
Fundamental
Operating Cash Flow (Qtr Discrete)
-80.55
N/A
+1.53%
Technical
Chart Pattern (252d)
figure_79
N/A
+1.37%
Sentiment
Fear & Greed Index (CNN)
31
N/A
-1.03%
Technical
Performance (YTD)
-0.28%
+-
+0.96%
Technical
Chart Pattern (120d)
figure_29
N/A
+0.67%
Fundamental
Operating Profit Margin
-12,532.47%
N/A
-0.60%
Sentiment
Earnings Countdown
-51
+-
+0.60%
Sentiment
Sentiment Impact (Long Tail)
-
N/A
+0.59%
Technical
-0.49%
Fundamental
+0.39%
Fundamental
+0.33%
Fundamental
-0.32%
Fundamental
-0.32%
Rest of Alpha Signals: +1.61%
  • EYPT probability advantage of beating the market (3M)Total:+10.44%
  • EYPT AI Score
Significant changes Vs previous day

EYPT Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

  • Entry:$13.22
  • Horizon: 3 months
  • Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 7/10
  • Take Profit:$XXXXXPro (XXXXX) or AI Score < 7/10

EYPT Average Past Performance & Win Rate

Three months after its 211 Buy signals since June 2026, EYPT had an average performance of xxxxxxx and a xxxxxx Win rate (positive performance).

211 Past EYPT Buy Signals
1 Month Later
3 Months Later
6 Months Later
1 Year Later
Average Performance
+79.53%
Average Alpha
+59.24%
Win Rate (% Positive Perf.)
95.65%
% Positive Alpha
80.87%

EYPT Past Buy Signals Performance

Date
AI Score
Perf. 1M
Perf. 3M
Perf. 6M
Perf. 1Y
Alpha. 1M
Alpha. 3M
Alpha. 6M
Alpha. 1Y

EYPT Frequently Asked Questions

EyePoint Inc Company Profile

Pros

Cons

  • EYPT / US30233G2093US Flag
  • Market Cap$1.11B
  • Short Float19.30%
  • Volume2.15M
  • Dividend %-
Performance
  • Perf Week-8.22%
  • Perf Quarter+2.52%
  • Perf Year+40.43%
  • Perf YTD-27.66%
Technical Indicators
  • 52W High18.85 -29.89%
  • 52W Low8.28 59.60%
  • Avg Volume978.17K
  • Beta1.74
  • ATR0.99
  • Volatility6.28% - 6.17%

EYPT Company Profile Summary

EYPT Related Investment Themes

EYPT Related Stocks

Company
AI Score
Compare

EYPT Top 10 Industry Stocks

Pharmaceuticals

Company
AI Score
Compare

EYPT Top 10 Sector Stocks

Health Care

Company
AI Score
Compare